Massin, Pascale; Bandello, Francesco; Garweg, Justus G; Hansen, Lutz L; Harding, Simon P; Larsen, Michael; Mitchell, Paul; Sharp, Dianne; Wolf-Schnurrbusch, U E K; Gekkieva, Margarita; Weichselberger, Andreas; Wolf, Sebastian (2010). Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes care, 33(11), pp. 2399-405. Alexandria, Va.: American Diabetes Association 10.2337/dc10-0493
Full text not available from this repository. (Request a copy)The expression of vascular endothelial growth factor (VEGF) is elevated in diabetic macular edema (DME). Ranibizumab binds to and inhibits multiple VEGF variants. We investigated the safety and efficacy of ranibizumab in DME involving the foveal center.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology |
UniBE Contributor: |
Wolf-Schnurrbusch, Ute, Wolf, Sebastian (B) |
ISSN: |
0149-5992 |
Publisher: |
American Diabetes Association |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:08 |
Last Modified: |
05 Dec 2022 14:00 |
Publisher DOI: |
10.2337/dc10-0493 |
PubMed ID: |
20980427 |
Web of Science ID: |
000284516400020 |
URI: |
https://boris.unibe.ch/id/eprint/429 (FactScience: 198899) |
Actions (login required)
 |
Edit item |